LUPIN.NS Balance Sheet
Lupin Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:36
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹46.45 Bn | ₹48.99 Bn | ₹51.48 Bn | ₹54.49 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹8.95 Bn | ₹5.96 Bn | ₹3.55 Bn | ₹6.95 Bn | CapitalWorkInProgress |
| Goodwill | ₹22.19 Bn | ₹23.25 Bn | ₹22.33 Bn | ₹26.59 Bn | Goodwill |
| Other Intangible Assets | ₹14.91 Bn | ₹16.55 Bn | ₹23.39 Bn | ₹28.86 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.47 Bn | ₹2.01 Bn | ₹0.60 Bn | ₹0.64 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹5.76 Bn | ₹2.45 Bn | ₹2.27 Bn | ₹2.17 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹105.05 Bn | ₹105.50 Bn | ₹124.06 Bn | ₹143.37 Bn | NoncurrentAssets |
| Inventories | ₹44.92 Bn | ₹49.54 Bn | ₹54.76 Bn | ₹60.83 Bn | Inventories |
| Trade Receivables | ₹44.81 Bn | ₹46.92 Bn | ₹54.97 Bn | ₹66.04 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹12.32 Bn | ₹9.83 Bn | ₹15.44 Bn | ₹41.68 Bn | CashAndCashEquivalents |
| Current Investments | ₹4.40 Bn | ₹8.47 Bn | ₹10.59 Bn | ₹35.77 Bn | CurrentInvestments |
| Other Current Assets | ₹11.51 Bn | ₹10.71 Bn | ₹12.52 Bn | ₹15.43 Bn | OtherCurrentAssets |
| Total Current Assets | ₹124.51 Bn | ₹134.48 Bn | ₹167.99 Bn | ₹240.27 Bn | CurrentAssets |
| Total Assets | ₹229.56 Bn | ₹239.97 Bn | ₹292.05 Bn | ₹383.65 Bn | Assets |
| Equity Share Capital | ₹0.91 Bn | ₹0.91 Bn | ₹0.91 Bn | ₹0.91 Bn | EquityShareCapital |
| Other Equity | ₹123.73 Bn | ₹141.99 Bn | ₹171.12 Bn | ₹223.57 Bn | OtherEquity |
| Equity Attributable to Owners | ₹124.64 Bn | ₹142.90 Bn | ₹172.03 Bn | ₹224.48 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.78 Bn | ₹0.83 Bn | ₹0.91 Bn | ₹0.65 Bn | NonControllingInterest |
| Total Equity | ₹125.43 Bn | ₹143.73 Bn | ₹172.94 Bn | ₹225.13 Bn | Equity |
| Long-term Borrowings | ₹0.28 Bn | ₹0.00 Bn | ₹17.66 Bn | ₹16.43 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹11.48 Bn | ₹11.22 Bn | ₹29.49 Bn | ₹32.00 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹42.17 Bn | ₹26.70 Bn | ₹33.10 Bn | ₹42.67 Bn | BorrowingsCurrent |
| Trade Payables | ₹25.32 Bn | ₹29.58 Bn | ₹29.58 Bn | ₹41.73 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹8.71 Bn | ₹11.44 Bn | ₹11.40 Bn | ₹16.49 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹92.65 Bn | ₹85.02 Bn | ₹89.61 Bn | ₹126.51 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹229.56 Bn | ₹239.97 Bn | ₹292.05 Bn | ₹383.65 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from LUPIN.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).